Parkinson’s UK is investing £2.1million to support Neumora Therapeutics to carry out preclinical testing of NMRA-NLRP3, a NLRP3 inhibitor with the potential to reduce inflammation and protect brain cells in Parkinson’s. NLRP3 is a protein that plays a role in regulating a number of inflammatory processes that are believed to contribute to the damage to brain cells that underlies Parkinson’s.
13 Indian Americans among 40 Science Talent Search finalists americanbazaaronline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from americanbazaaronline.com Daily Mail and Mail on Sunday newspapers.
73 Indian Americans among top 300 high school scholars americanbazaaronline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from americanbazaaronline.com Daily Mail and Mail on Sunday newspapers.
To test new stroke treatments, a research team from the Keck School of Medicine of USC develops a more rigorous system for conducting preclinical research that could lead to more successful clinical trials.